Entyvio 300 MG vials
Ended Awarded
- Contract number
- SPE2DB25FZC74
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $49,449
Award facts
- Contract value 100% obligated
- $49,449.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $49,449.30 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Entyvio 300 mg vials. This firm fixed-price delivery order, issued on September 8, 2025, with an ultimate completion date of September 29, 2025, represents a direct procurement with no set-aside designation. The award leverages DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.999 billion vehicle valid through November 2026 that enables the agency to issue delivery orders for comprehensive pharmaceutical products supporting military health facility needs worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain, with a proven track record of delivering specialized medications including biologics, branded and generic prescription drugs, and medical consumables to Department of Defense healthcare sites. The company's expertise in oncology treatments, specialty injectables, and other advanced pharmaceuticals positions it well to support military medical operations. This delivery order for Entyvio, a specialty pharmaceutical product, exemplifies the company's role in supplying specialized therapeutic agents to federal healthcare systems serving active duty personnel and military beneficiaries.
Quick answers
Who was awarded contract SPE2DB25FZC74?
SPE2DB25FZC74 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 8, 2025.
How much is contract SPE2DB25FZC74 worth?
The government has obligated $49,449 on SPE2DB25FZC74.
Is contract SPE2DB25FZC74 an order under another contract?
Yes. SPE2DB25FZC74 is a delivery order under SPE2DB22D9143, an indefinite delivery contract.
Was contract SPE2DB25FZC74 competed?
The extent of competition for SPE2DB25FZC74 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award